Page last updated: 2024-10-31

metronidazole and Dientamoeba fragilis Infection

metronidazole has been researched along with Dientamoeba fragilis Infection in 22 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Research Excerpts

ExcerptRelevanceReference
"Metronidazole treatment had a short-term impact on the abundance of some bacterial genera, with most of these reverting to pretreatment levels 8 weeks after completed treatment."3.01Impact of Metronidazole Treatment and Dientamoeba Fragilis Colonization on Gut Microbiota Diversity. ( Andersen, LO; Gotfred-Rasmussen, H; Ingham, AC; Johannesen, TB; Nielsen, HV; Röser, D; Stensvold, CR, 2021)
"Metronidazole is a well-known and commonly used anti-protozoal agent, but another 5-nitroimidazole derivative, ornidazole, may be preferable, where available, because of its longer half-life and fewer side-effects."2.73A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. ( Balcioğlu, IC; Girginkardeşler, N; Kurt, O; Ok, UZ; Ozbilgin, A, 2008)
"Metronidazole was the therapeutic option in most cases, followed by paromomycin: 65."1.51Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment. ( Abellana, R; Burgaña, A; García-Puig, R; Gonçalves, AQ; Hernández, CG; Kazan, R; Padilla, E; Pérez Ortiz, AM; Pérez, J; Perez-Porcuna, TM; Ramos, CC; Rivero, MM; Yordanov, SZ, 2019)
"Metronidazole treatment failure was significantly more frequent in patients with E."1.43Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection? ( Boga, JA; Fernández, J; Iglesias, C; Martínez-Camblor, P; Rodríguez, M; Rodríguez-Guardado, A; Rojo, S; Vázquez, F, 2016)
"Recurrence of the symptoms and recurrence of the D."1.42[Dientamoeba fragilis infection as cause of severe abdominal discomfort and flatulence]. ( Halkjær, S; Petersen, AM; Stensvold, CR, 2015)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19903 (13.64)18.7374
1990's0 (0.00)18.2507
2000's6 (27.27)29.6817
2010's10 (45.45)24.3611
2020's3 (13.64)2.80

Authors

AuthorsStudies
Montraveta-Querol, M1
Bovo, MV1
Roig-Abraham, N1
Romaní, N1
Alcaraz, A1
Fernández-Rivas, G1
Burgaña, A1
Abellana, R1
Yordanov, SZ1
Kazan, R1
Pérez Ortiz, AM1
Ramos, CC1
Hernández, CG1
Rivero, MM1
Gonçalves, AQ1
Padilla, E1
Pérez, J1
García-Puig, R1
Perez-Porcuna, TM1
Clemente, L1
Pasut, M1
Carlet, R1
Ruscio, M1
Fontana, F1
Gotfred-Rasmussen, H1
Stensvold, CR5
Ingham, AC1
Johannesen, TB1
Andersen, LO1
Röser, D2
Nielsen, HV4
Menéndez, C1
Fernández-Suarez, J1
Boga Ribeiro, JA1
Rodríguez-Pérez, M1
Vázquez, F2
Gonzalez-Sotorrios, N1
Rodríguez-Guardado, A2
Simonsen, J1
Olsen, KE2
Bytzer, P2
Mølbak, K2
de Jong, MJ1
Korterink, JJ1
Benninga, MA1
Hilbink, M1
Widdershoven, J1
Deckers-Kocken, JM1
Halkjær, S1
Petersen, AM1
Boga, JA1
Rojo, S1
Fernández, J1
Rodríguez, M1
Iglesias, C1
Martínez-Camblor, P1
Lewis, HC1
Hammerum, AM1
Porsbo, LJ1
Nielsen, SS1
Arendrup, MC1
Lankester, F1
Kiyang, JA1
Bailey, W1
Unwin, S1
Banik, GR1
Barratt, JL1
Marriott, D1
Harkness, J1
Ellis, JT1
Stark, D1
Engsbro, AL1
Schure, JM1
de Vries, M1
Weel, JF1
van Roon, EN1
Faber, TE1
Girginkardeşler, N2
Coşkun, S1
Cüneyt Balcioğlu, I1
Ertan, P1
Ok, UZ2
Norberg, A1
Nord, CE1
Evengård, B2
Ito, R1
Sakagami, J1
Kataoka, K1
Nakamura, H1
Motoyoshi, T1
Takada, R1
Kanemitsu, D1
Yasuda, H1
Mitsufuji, S1
Okanoue, T1
Kurt, O1
Balcioğlu, IC1
Ozbilgin, A1
Wolfe, MS1
Lindström, J1
Spencer, MJ1
Garcia, LS1
Chapin, MR1
Turner, JA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Metronidazole for the Treatment of Dientamoebiasis in Children in Denmark - A Randomized, Placebo-controlled, Double-blinded Clinical Trial[NCT01314976]Phase 4100 participants (Anticipated)Interventional2011-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for metronidazole and Dientamoeba fragilis Infection

ArticleYear
The treatment of intestinal protozoan infections.
    The Medical clinics of North America, 1982, Volume: 66, Issue:3

    Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoeb

1982
[Dientamoeba fragilis--an old parasite sparks new interest].
    Lakartidningen, 2001, Jul-25, Volume: 98, Issue:30-31

    Topics: Animals; Antitrichomonal Agents; Dientamoeba; Dientamoebiasis; Feces; Humans; Metronidazole

2001
Giardiasis and infections with Dientamoeba fragilis.
    Pediatric clinics of North America, 1985, Volume: 32, Issue:4

    Topics: Adult; Amebiasis; Animals; Cats; Child; Child, Preschool; Dientamoeba; Dientamoebiasis; Dogs; Female

1985

Trials

4 trials available for metronidazole and Dientamoeba fragilis Infection

ArticleYear
Impact of Metronidazole Treatment and Dientamoeba Fragilis Colonization on Gut Microbiota Diversity.
    Journal of pediatric gastroenterology and nutrition, 2021, 07-01, Volume: 73, Issue:1

    Topics: Child; Dientamoeba; Dientamoebiasis; Feces; Gastrointestinal Microbiome; Humans; Metronidazole

2021
Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:12

    Topics: Anti-Infective Agents; Child; Child, Preschool; Denmark; Dientamoebiasis; Double-Blind Method; Femal

2014
Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Child; Child, Preschool; Diarrhea; Dientamoeba; Di

2003
A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amebicides; Animals; Antiprotozoal

2008

Other Studies

15 other studies available for metronidazole and Dientamoeba fragilis Infection

ArticleYear
Should Dientamoeba fragillis be looked for in pediatric digestive pathology of an unknown cause? A proposed pilot case-control study.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2022, Volume: 40, Issue:8

    Topics: Case-Control Studies; Child; Dientamoeba; Dientamoebiasis; Humans; Metronidazole; Real-Time Polymera

2022
Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.
    International journal for parasitology. Drugs and drug resistance, 2019, Volume: 11

    Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Dientamoeba; Dientamoebiasis; Feces; Female; Humans;

2019
Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment.
    Parasitology international, 2021, Volume: 80

    Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Cross-Sectional Studies; Die

2021
Epidemiological and clinical characteristics of Dientamoeba fragilis infection.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:5

    Topics: Adult; Antiprotozoal Agents; Dientamoebiasis; Female; Humans; Male; Metronidazole; Middle Aged; Paro

2019
Dientamoeba fragilis and chronic abdominal pain in children: a case-control study.
    Archives of disease in childhood, 2014, Volume: 99, Issue:12

    Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Case-Control Studies; Child; Chronic Disease; Clio

2014
[Dientamoeba fragilis infection as cause of severe abdominal discomfort and flatulence].
    Ugeskrift for laeger, 2015, Jan-26, Volume: 177, Issue:2A

    Topics: Adolescent; Dientamoeba; Dientamoebiasis; Feces; Flatulence; Humans; Male; Metronidazole; Recurrence

2015
Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection?
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 49

    Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Antiprotozoal Agents; Child; Child, Preschool; Coin

2016
Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite.
    Epidemiology and infection, 2009, Volume: 137, Issue:11

    Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Blastocystis; Blastocystis Infections; Child

2009
Dientamoeba fragilis: initial evidence of pathogenicity in the western lowland gorilla (Gorilla gorilla gorilla).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2010, Volume: 41, Issue:2

    Topics: Animals; Antiprotozoal Agents; Ape Diseases; Dientamoeba; Dientamoebiasis; Feces; Female; Gorilla go

2010
A case-controlled study of Dientamoeba fragilis infections in children.
    Parasitology, 2011, Volume: 138, Issue:7

    Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Australia; Case-Control Studies; Child; Child, Pre

2011
Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.
    The American journal of tropical medicine and hygiene, 2012, Volume: 87, Issue:6

    Topics: Adult; Antiprotozoal Agents; Denmark; Dientamoeba; Dientamoebiasis; Feces; Female; Humans; Irritable

2012
Symptoms and treatment of Dientamoeba fragilis infection in children, a retrospective study.
    The Pediatric infectious disease journal, 2013, Volume: 32, Issue:4

    Topics: Adolescent; Antiprotozoal Agents; Child; Child, Preschool; Clioquinol; Dientamoebiasis; Feces; Femal

2013
Dientamoeba fragilis--a protozoal infection which may cause severe bowel distress.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Animals; Anti-Infective Agents; Child; Child, Preschool; Diarrhea; Dientamo

2003
Chronic diarrhea and protein-losing gastroenteropathy caused by Dientamoeba fragilis.
    Journal of gastroenterology, 2004, Volume: 39, Issue:11

    Topics: Aged; Antiprotozoal Agents; Biopsy; Chronic Disease; Colon; Diarrhea; Dientamoebiasis; Feces; Female

2004
Dientamoeba fragilis. An intestinal pathogen in children?
    American journal of diseases of children (1960), 1979, Volume: 133, Issue:4

    Topics: Amebiasis; Child; Child, Preschool; Dientamoebiasis; Female; Gastrointestinal Diseases; Humans; Infa

1979